Xiangyu Medical: Over 80 Major Hospitals Adopt Its BCI Rehabilitation Devices as Company Files Prospectus

Source: China Securities Journal·China Securities Network

China Securities News (Wang Lu) October 20th,Sunnyou MedicalSunnyou stated in the disclosure of investor relations activity records that the company has achieved independent development in five key areas: brain-computer interface hardware, chips, electrodes, algorithms, and brain-computer interactive rehabilitation devices.

Sunnyou Medical introduced that the company's brain-computer interface technology is seamlessly connected with a variety of self-developed rehabilitation devices, covering rich treatment scenarios from physical therapy factors to movement rehabilitation, cognitive speech rehabilitation, and mental psychological rehabilitation. For different scenarios, a comprehensive brain-computer interface solution has been carefully designed, establishing an integrated "acquisition-algorithm-control-scenario" ecosystem. This supports hospitals at all levels in building brain-computer interface neuromodulation rehabilitation treatment and clinical research transformation centers, creating regional treatment benchmarks.

Sunnyou's self-developed and self-produced EEG acquisition devices come in multiple models, including dry electrodes, wet electrodes, and saline electrodes. They offer high patient comfort, with notable advantages such as high data transmission quality, high sampling rate, strong anti-interference capability, and low impedance. In key performance parameters like signal transmission rate and common mode rejection ratio, Sunnyou's products hold a competitive edge among similar devices.

Regarding the sales forecast for brain-computer interface products, Sunnyou Medical revealed that currently, more than 80 large hospitals are using the company’s brain-computer interface rehabilitation equipment. As new products equipped with brain-computer interface technology gradually obtain registration certificates and enter the market, they will become a new growth point for the company's performance. Given that the bidding and tendering process requires a certain period, the company’s brain-computer interface products are expected to contribute to its financial performance by 2025, and significant improvements in performance are anticipated in 2026.